Viewing Study NCT02419560


Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2026-01-07 @ 10:29 AM
Study NCT ID: NCT02419560
Status: COMPLETED
Last Update Posted: 2022-05-24
First Post: 2015-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Optimal Dose Finding Study ABT-199 and Ibrutinib in MCL
Sponsor: Craig Portell, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module